Quantum Biopharma Ltd. Files April 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Apr 1, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, pharmaceutical
TL;DR
Quantum Biopharma (fka FSD Pharma) filed their April 6-K, confirming 20-F reporting.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on April 1, 2025, reporting for the month of April 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, operates in the Pharmaceutical Preparations sector. This filing indicates they are submitting their report under Form 20-F.
Why It Matters
This filing provides an update on Quantum Biopharma's regulatory reporting status, confirming their submission of a Form 6-K for April 2025 and their adherence to Form 20-F requirements.
Risk Assessment
Risk Level: low — This is a routine periodic filing (6-K) that does not contain new material financial or operational information.
Key Numbers
- 001-39152 — SEC File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former company name
- April 1, 2025 (date) — Filing date
- 20250401 (date) — Period of report
- 001-39152 (other) — SEC file number
- Form 20-F (other) — Annual report form
- Form 6-K (other) — Report type
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of April 2025.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former company name was FSD Pharma Inc., with a date of name change on March 27, 2019.
In which industry sector does Quantum Biopharma Ltd. operate?
Quantum Biopharma Ltd. operates in the Pharmaceutical Preparations sector, with Standard Industrial Classification code 2834.
What is the company's principal executive office address?
The company's principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Does Quantum Biopharma Ltd. file its annual reports under Form 20-F or Form 40-F?
Quantum Biopharma Ltd. indicates by check mark that it files or will file annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 1, 2025 regarding Quantum Biopharma Ltd. (QNTM).